medigraphic.com

2006, Number 4

<< Back Next >>

Arch Cardiol Mex 2006; 76 (4)

Understanding heart failure

Guadalajara BJF

Language: Spanish
References: 67
Page: 431-447
PDF size: 279.03 Kb.


ABSTRACT

Heart failure is a disease with several definitions. The term “heart failure“ is used by has brougth about confusion in the terminology. For this reason, the value of the ejection fraction (< 0.40 or < 0.35) is used in most meganalyses on the treatment of heart failure, avoiding the term “heart failure” that is a confounding concept. In this paper we carefully analyze the meaning of contractility, ventricular function or performance, preload, afterload, heart failure, compensation mechanisms in heart failure, myocardial oxygen consumption, inadequate, adequate and inappropriate hypertrophy, systole, diastole, compliance, problems of relaxation, and diastolic dysfunction. Their definitions are supported by the original scientific descriptions in an attempt to clarify the concepts about ventricular function and heart failure and, in this way, use the same scientific language about the meaning of ventricular function, heart failure, and diastolic dysfunction.


REFERENCES

  1. Parmley W: Pathophysiology and Current Therapy in Congestion Heart Failure. J Am Coll Cardiol 1989; 13: 771-785.

  2. Francis GS, Goldsmith SR, Olivare MT: The Neurohumoral Axis in Congestive Heart Failure. Ann Intern Med 1984; 101: 370-377.

  3. Eichhorn EJ, Bristow MR: Medical Therapy can Improve the Biological Properties of the Chronically Failing Heart a New era in the Treatment of Heart Failure. Circulation 1996; 94: 2285-2296.

  4. Van Veldhuisen DJ, Graeff PA, Remme WJ: Value of Digoxin in Heart Failure and Sinus Rhythm: New Features of an Old Drug? J Am Coll Cardiol 1996; 28: 813-819.

  5. Pfeffer MA, Braunwald E, Mayo LA: The Effect of Captopril on Mortality With Left Ventricular Disfunction Following Myocardial Infarction, Results of the Survival and Ventricular Enlargament (SAVE) Trial. N Engl J Med 1992; 327: 669-677.

  6. Pitt B, Zannad F, Remme WJ, Cody R: The Effect of Spironolactone on Morbidity and Mortality in Patients With Severe Heart Failure. N Engl J Med 1999; 341: 709-717.

  7. Corson P, Anand I, O´Connor C, Jasky B, Steimberg J, Lwin A, et al: Mode of Death in Advanced Heart Failure The Comparison of Medical, Pacing and Defibrillation Therapy is Heart Failure (COMPANION) Trial. J Am Coll Cardiol 2005; 46: 2329-2334.

  8. Bax J, Palderman D, Elhendy A, Correll JH, Boersma E Rainbaldi R, Roelant RTC: Improvement Left Ventricular Ejection Fraction Heart Failure Syntoms and Prognosis After Revascularization in Patients With Chronic Coronary Artery Disease and Viable Myocardium Detected by Dobutamine Stress Echocardiography. J Am Cardiol 1999; 34: 163-169.

  9. Koerner MM, Bernard Durand J, La Fuente JA, Noon GP, Torre Amione G: Cardiac Transplantation: The Final Therapeutic Option for the Treatment of Heart Failure. Curr Opin Cardiol 2000; 15: 178-182.

  10. Rose EA, Gelijns AC, Moskowitz AJ: Long Term Use of Left Ventricular Assist Device for end Stage Heart Failure. N Engl J Med 2001; 345: 1435-1443.

  11. Poole-Wilson PA, Colucci WS, Massie BM, Chatterjee K, Coats AJ: History, Definition and Classification of Heart Failure. Eds. Churchill-Livingstone 1997: 269-277.

  12. Golberg LR, Jessup M: Stage B. Heart Failure. Management of Asymptomatic Left Ventricular Systolic Dysfunction. Circulation 2006; 113: 2851-2860.

  13. Ross J Jr: Cardiac Function and Myocardial Contractility. A Perspective. J Am Coll Cardiol 1983; 1: 52-59.

  14. Ford L: Mechanical Manifestations of Activation in Cardiac Muscle. Circ Res 1991; 68: 621-625.

  15. Brutsaert DL, Sonnenblick EH: Cardiac Muscle Mechanics in the Evaluation of Myocardial Contractility and Pump Function: Problems, Concepts and Directions. Prog Cardiovasc Dis 1973; 16: 337.

  16. Suga H, Sagawa K: Instantaneons Pressure-Volume Relationships and Their Ratio in the Excised Supported Canine Left Ventricle. Circ Res 1974; 35: 117-122.

  17. Carabello BA: Ratio of End-Systolic Stress to End-Systolic Volume: It is a Useful Clinical Tool? J Am Coll Cardiol 1989; 14: 496-498.

  18. Carabello BA, Stanton PN, Cockhart BM: Assessment of Preoperative Left Ventricular Function in Patients With Mitral Regurgitation: Value of the En-Systolic Wall Stress- End-Sytolic Volume Ratio. Circulation 1981; 64: 1212-1217.

  19. Braunwald E, Ross J Jr: Control of Cardiac Performance. En: Berne R.M. ED Handbook of Physiology. Am Soc Phisiol 1979; 1: 533-580.

  20. Forrester JS, Diamond G, Chatterjee K, Swan HJC: Medical Therapy of Acute Myocardial Infarction by Application of Hemodynamic Subses. Engl J Med 1976; 295: 1404-1413.

  21. Volpi A, De Vita C, Franzosi MG, Gerasi E, Mauri F, Negri E, et al: Determinants of 6-monts Mortality in Survivors of Myocardial Infarction After Thrombolisys Results of the Gissi – 2 Data Base. Circulation 1993; 88: 416-429.

  22. Hirota Y, Shimisu G, Kawamura K: Assessment of Cardiac Function in Diseased Heart by Catheterization Study. En Hori, Suga, Baan, Yellin Eds. “Cardiac Mechanics and Function is Normal and Diseased Heart. Tokio Springer-Verlag 1989: 283-290.

  23. Schunkeert H, Jahn L Izumo S, Apstein CS, Losrell HH: Localization and relation of c-fos and c-jun proatooncogene induction by systolic wall stress in normal and hypeertrhopied rat hearts. Proc Natl Acad Sci 1991; 88: 11480-11484.

  24. Weber KT, Janicky JS: Myocardial Oxygen Consumption, the Role of Wall Force and Shortening. Am J Physiol 1977; 233(4): H421-H430.

  25. Sonnenblick EH, Ross J Jr, Braunwald E: Oxigen Consumption of the Heart. Am J Cardiol 1986; 22: 328-334.

  26. Besse P: Indices of Function: Invasive Exploratory Methods. En Cardiac Hypertrophy and Failure. Swyndhedaw B. Ed. Inserm y Johnlibbey Co. Francia Eurotext. 325-351.

  27. Cohn JN, Jonson G: Heart Failure With Normal Ejection Fraction. The V-Heft Study Group. Circulation 1990; 81: 48-53.

  28. Colan ED, Borow KM, Neumann A: Left Ventricular Wall Stress-Velocity of Fiber Shortening Relation: A Load Independent index of Myocardial Contractility. J Am Coll Cardiol 1984; 4: 715-723.

  29. Gunther S, Grossman W: Determinants of Ventricular Function in Pressure Overload Hypertrophy in Man. Ciculation 1979; 59: 679-687.

  30. Ash R, Fisher D: Manifestations and Results of Treatment of Patent Ductus Arteriosus in Infancy and Childhood. An Analysis of 138 Cases. Pediatrics 1955; 16: 695-706.

  31. Carabello BA, Green LH, Grossman W, Cohn L, Koster JK, Collins JJ: Hemodynamic Determinants of Prognosis of Aortic Value Replacement in Critical Aortic Stenosis and Advanced Congestive Heart Failure. Circulation 1980; 62: 42-48.

  32. Starling MR, Kirsh MM, Monteomery DG, Gross MD: Impaired Left Ventricular Contractile Function in Patients With Long-Term Mitral Regurgitation and Normal Ejection Fraction. J Am Coll Cardiol 1993; 22: 234-250.

  33. Weber K, Anversa P, Armstrong WP: Remodeling and Reparation of the Cardiovascular System. J Am Coll Cardiol 1992; 20: 3-16.

  34. Ross J Jr: Afterload Mismatch in Aortic and Mitral Valve Disease. Implications for Surgical Therapy. J Am Coll Cardiol 1985; 5: 811-826.

  35. Weber KT, Janicky JS: The Heart as a Muscle-Pump System and the Concept of Heart Failure. Am Heart J 1979; 98: 371-384.

  36. Sasayama S, Gallagher KP, Kemper S, Franklin D, Ross J Jr: Regional Left Venricular Thickness Early and Late After Coronary Oclussion in the Conscious Dog. Am J Physiol 24: H293-H299.

  37. Swan HJC, Forrester JS, Diamond G: Hemodynamic Spectrum of Myocardial Infarction and Cardiogenic Shock. Circulation 1972; 45: 1097-1103.

  38. Webb JC, Sanborn TA, Sleeper TA: Percutaneous Coronary Intervention in the Management of Cardiogenic Shock in the SHOCK registry. Am Heart J 2001; 44: 974-970.

  39. Mason DT: Congestive Heart Failure, Mechanims, Evaluation and Treatment. York Med Books, New York, 1976. p.1.

  40. Guadalajara JF: ¿Qué es la Insuficiencia Cardíaca? Arch Inst Cardiol Mex 1998; 68:7-11.

  41. Guadalajara JF: ¿Existe la Insuficiencia Cardíaca Diastólica? Arch Inst Cardiol Mex 2003; 73: 291-300.

  42. Brandt RR, Wright S, Redfield MM: Atrial Natriuretic Peptide in Heart Failure. J Am Coll Cardiol 1993; 22 (Suppl. A): 86A-92A.

  43. Mahler F, Yoran C, Ross Jr J: Inotropic Effect of Tachicardia and Poststimulation in the Consciencius Dog. Am J Physiol 1974; 227: 569-575.

  44. Dzau VJ, Colucci WS, Hollemberg NK, William GH: Relation of the Renin-Angiotensin-Aldosterone System to Clinical State in Congestive Heart Failure. Circulation 1981; 63: 645-651.

  45. Gaasch WH: Left Ventricular Radius to Wall Thickness Ratio. Am J Cardiol 1979; 43: 1189-1194.

  46. Grossman W: Cardiac Hypertrophy: Useful Adaptation or Pathologic Process. Am J Med 1980; 69: 576-584.

  47. Thiedemann KU, Holeibarsch C, Mediegorac I, Jacob R: Connective Tissue Content and Myocardial Stiffness in Pressure Overload Hypertrophy: A combined Study of Morphologic, Morphometric, Biochemical and Mechanical Parameters. Basic Res Cardiol 1983; 78: 140-155.

  48. Hanrath P, Mathey DG, Siegent R, Bleifield W: Left Ventricular Relaxation and Filling Pattern in Diferent Forms of Left Ventricular Hypertrophy: An Echocardiografic Study. Am J Cardiol 1980; 45: 15-23.

  49. Linz Bach AJ: Heart Failure From the Point of View of Cuantitative. Am J Cardiol 1960; 5: 370-382.

  50. Strauer BE: Hypertensive Heart Disease. En Cardiac Hypertrophy and Failure. (Ed. Swynghedaw B). Inserm/John Libbey Eurotext; 1990: 443-465.

  51. Guadalajara JF, Martinez SC, Huerta D: La Relación grosor/radio (h/r) del Ventrículo Izquierdo en la Estenosis Aórtica. Implicaciones Diagnósticas y Terapéuticas. Arch Inst Cardiol Mex 1990; 60: 383-391.

  52. Osbakken M, Bave A, Spann JF: Left Ventricular Function in Chronic Aortic Regulation With Reference to Systolic Pressure/Volume and Stress Relation. Am J Cardiol 1981; 47: 193-198.

  53. Senni M, Tribovilloy CM, Rodeheffer RJ, Jalobsen SJ, Evans JM, Bailey KR, Redfield HM: Congestive Heart Failure in the Community. A Study in all Incident Cases in Olmsted County, Minnesota, in 1991. Circulation 1998; 98: 2282-2289.

  54. Wang TJ, Evans JC, Benjamin EJ, Levy D, Le Roy EC, Vasan RS: Natural History of Asinptomatic Left Ventricular Systolic Dysfunction in the Community. Circulation 2003; 108: 977-982.

  55. Raukin S, Lucke EJ, Gaynor W, Harpole DH, Feneley MP, Nikolic S, et al: An Energetic Analysis of Myocardial Performance In: Cardiac Mechanics and Function in the Normal and Diseased Heart. (Eds. Hori M, Suga H, Baan J, Yellin EL). Springer-Velay. 1989: 165-188.

  56. Sy SSU, Brutsaert DL: Systolic Relaxation in the Intac Heart. Research in Cardiac Hypertrophy and Failure. Ed. Swynghedaw Inserm/John Libbery. Eurotext 1990: 353-365.

  57. Grossman W, Lorell BH: Diastolic Relaxation of the Heart. Boston. Mortinus Nijhoff, 1988.

  58. Grossman W, Mann JT: Evidence for Impaired Left Ventricular Relaxation During Acute Ischemia in Man. Eur J Cardiol 1978; 7(Suppl): 239-249.

  59. Gaasch WH: Clinical Diagnosis and Management of Left Ventricular Diastolic Dysfunction In: Cardiac Mechanics and Function in the Normal an Diseased Heart. (Eds. Hori M., Suga H., Baan J., Yellin E.L). Springer-Verlag 1989: 291-298.

  60. Glantz SA, Gilbert JC: Determinants of Diastolic Function in Cardiac Mechanics and Function in the Normal and Diseased Heart. (Eds. Hori M., Suga H., Baan J., Yellin E.L). Springer-Verlag 1989: 103-120.

  61. Vasan RS: Defining Diastolic Heart Failure. A Coll for Standardized Diagnostic Criteria. Circulation 2000; 101: 2118-2221.

  62. Brogan WC, Hillis LD, Flores ED, Lange RA: The Natural History of Isolated Left. Ventricular Diastolic Dysfunction. Am J Med 1992; 92: 627-630.

  63. Diamond G, Forrester JS, Hergis J, Parmley WW, Danzing R, Swan HJC: Diastolic Pressure-Volume Relationships in Canine Left Ventricle. Circ Res 1971; 29: 267-275.

  64. Aronow WS: Epidemiology, Pathophysiology, Prognosis and Treatment of Systolic and Diastolic Heart Failure. Cardiology in Review 2006; 14: 108-124.

  65. Benedict CR, Weiner DH, Johnston DE, Bourasa M, Ghali JK: Comparative Neurohormonal Responses in Patients With Preserved and Impaired Left Ventricular Ejection Fraction: Results of the Studies of Left Ventricular Dysfunction (Solvd Registry). J Am Coll Cardiol 1993; 22: (Suppl A): 146A-153A.

  66. Curtis JP, Sokol SI, Wang Y, Rathore SS, Ko DT, Jadbabaie F: The Association of Left Ventricular Ejection Fraction Mortality as Cause of Death in Stable out Patients With Heart Failure. J Am Coll Cardiol 2003; 42: 736-742.

  67. Senni M, Redfield MM: Heart Failure With Preserved Systolic Function A Different Natural History? J Am Coll Cardiol 2001; 38: 1277-1282.




2020     |     www.medigraphic.com